Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

C Dumontet, BI Sikic - Journal of Clinical Oncology, 1999 - ascopubs.org
PURPOSE: To analyze the available data concerning mechanisms of action of and
mechanisms of resistance to the antitubulin agents, vinca alkaloids and taxanes, and more …

Mechanisms of action and resistance to tubulin-binding agents

C Dumontet - Expert Opinion on Investigational Drugs, 2000 - Taylor & Francis
Tubulin binding agents constitute an important class of antimitotics and are widely used for
the treatment of solid tumours an haematopoietic malignancies. These compounds, currently …

Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients

J Carles, M Domenech, A Gelabert-Mas, M Nogue… - Acta …, 1998 - Taylor & Francis
The purpose of this study was to evaluate the antitumor activity of vinorelbine and oral
estramustine phosphate in patients with metastatic, hormone-refractory prostate cancer. We …

[PDF][PDF] Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization

C Dumontet, JP Jaffrezou, E Tsuchiya… - Bulletin du …, 2004 - lab.research.sickkids.ca
A vinblastine resistant cell line, KCVB2, was established by co-selecting the parental
erythroleukemic cell line K562 with step-wise increased concentrations of vinblastine …

New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience

N Saijo - Chest, 1998 - Elsevier
Non-small cell lung cancer (NSCLC) is refractory to systemic chemotherapy, compared with
small cell lung cancer. Until recently, only five drugs—cisplatin, vindesine, mitomycin …

In vitro and clinical studies: Paclitaxel and vinorelbine in non-small-cell lung cancer

AY Chang, R Devore, C Gu, P Keng, R Asbury - Oncology, 1997 - pure.johnshopkins.edu
Abstract Paclitaxel (Taxol) and vinorelbine (Navelbine) are both microtubule toxins but with
opposite mechanisms of action, Paclitaxel promotes the assembly of microtubules, whereas …

Chemotherapy for advanced (stage IIIB and stage IV) non‐small cell lung cancer: The Hong Kong perspective

WK LAM, KWT TSANG, MSM IP - Respirology, 1998 - Wiley Online Library
Non‐small cell lung cancer (NSCLC) accounts for about 80% of all primary lung cancers,
and 60% of cases present as advanced stages IIIB and IV disease. Traditionally, treatment of …

Chemotherapy for advanced non-small-cell lung cancer: role of paclitaxel and gemcitabine

WK Lam, KWT Tsang, MSM Ip - Hong Kong Medical Journal, 1999 - hub.hku.hk
Objective. To review the role of chemotherapy in advanced non-small-cell lung cancer,
focusing on cisplatin-based regimens and two new drugs: paclitaxel and gemcitabine. Data …

Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer

N Tomonaga, Y Nakamura, H Soda… - Cancer chemotherapy …, 2008 - Springer
Introduction Vinorelbine alone and irinotecan alone have been shown to have efficacy
against non-small cell lung cancer (NSCLC); each drug has different mechanisms of action …

[引用][C] Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine.

J Liebmann, K Friedman - The American journal of medicine, 1996 - europepmc.org
Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …